Healthcare >> CEO Interviews >> October 26, 2004
KENT SNYDER is President, Chief Executive Officer and Chairman of the Board of
Directors of Senomyx, Inc. Prior to joining Senomyx in June 2003, he held
various marketing and sales management positions with Agouron Pharmaceuticals,
Inc., a Pfizer company. Mr. Snyder was President of Global Commercial Operations
at Agouron after having served as Senior Vice President of Commercial Affairs
and Vice President of Business Development. Mr. Snyder is a director of
Santarus, Inc., a publicly held biopharmaceutical company, and VentiRx
Pharmaceuticals, Inc., a privately held biopharmaceutical company. Mr. Snyder
received his B.S. from the University of Kansas and his MBA from Rockhurst
College. Profile
Mr. Snyder: Senomyx is a biotechnology company which utilizes
proprietary taste receptor-based assays, high-throughput screening and
optimization chemistry to discover
